The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease durationSarah Opie-Martin, Christopher E. Shaw, Alfredo Iacoangeli et al.|Nature Communications|2022Cited by 59
Clinical trials in pediatric ALS: a TRICALS feasibility studyTessa Kliest, Martin R. Turner, Ruben P. A. van Eijk et al.|Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration|2022Cited by 12
Molecular dynamics analysis of Superoxide Dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progressionMunishikha Kalia, Robert H. Brown, Tommaso Biagini et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 7